Later, the authors discussed the falsificationist ideas of Karl Popper in relation to the black ravens: "the observation of a single nonblack raven will falsify the hypothesis that all ravens are black." Huff (2) recently discussed the role of cell proliferation in chemical carcinogenesis. At one point he discussed the ability of certain putatively nongenotoxic chemicals to induce renal cancer in male rats. The section in question is worth quoting in frill.
Meanwhile regulators and administrators should continue to be considerably cautious before embracing a purported mechanism-even a reasonable proposed hypothetical mechanism of carcinogenesis-as being pivotal to public health decisions. One example still garnering considerable debate centers on whether chemicals that induce cancers of the tubular cell epithelium of the kidney in male rats, concomitant with an increase in cell proliferation and testosterone-mediated ca-2p-globulin protein are relevant or useful to overall hazard identification for humans. The U.S. Environmental Protection Agency (for example) has embraced the concept that these experimental carcinogenic responses are not important to the human situation, whereas others (e.g., the Interational Agency for Research on Cancer) appear properly cautious, or have proposed equally reasonable alternative hypotheses. For example, and yet to be clarified, there are several chemicals known to induce this specific nephropathy syndrome that do not cause kidney cancers, and may or may not produce cancers in other organs; this lack of consistency must be explained.
Huff has seen some white ravens, but he has not identified them for other interested parties to study. I too have heard similar rumors, but I have yet to see a convening of the chemical structure, genetic toxicity, hyalin droplet data, and adequate rat cancer bioassay data for such a chemical. Given the importance of the issue under discusion, it would be valuable if Huff were to identify the chemicals to which he referred and present the relevant data for them in a focused paper. This would enable the commissioning of research to elucidate whether the a2p-globulin male rat renal cancer hypothesis should be retained or abandoned. Equally, when the available data are scrutinized, and perhaps extended, it may be possible to retain the hypothesis for use under qualified conditions; for example, it may be concluded that the persistence or magnitude of the nephropathy, as opposed to its presence, is the critical parameter.
The surest way to make progress in assessment of the hazard posed to humans by rodent carcinogens is for exceptions to current models to be clearly identified and made the subject of active research. In (1) proposes that "it may be possible to retain the hypothesis for use under qualified conditions." Ideally, I have little difficulty with his suggestion; however, in practice, the workability of such nuances is nearly impossible. Recall that "as it happens often in science, a timid suggestion at the end of a discussion, a carefully worded hypothesis, become transformed in the next paper (often by other authors) into a fact" (2) . Perhaps this is what happened to the a2p-globulin hypothesis, without the attendant necessary search for white ravens. Some have associated this testosterone-mediated protein with tumors of the kidney-in male rats. Importantly, a plausible rationale has yet to be offered to explain why certain a2p-globulin-provoking chemicals fail to systematically induce renal tubular cell tumors. Early on, in fact, several of us have raised basic issues about this purported mechanism (3) (4) (5) .
Hence, from my personal perspective in the sensitive area of human health and life, one must ignore the scientific urge to retain such tentative and "footnoted" hypotheses because proof, acceptance, and utilization for public health purposes must remain sacrosanct and on a firm foundation, especially when the use of said limited proof allows greater potential risks to be propagated or perpetrated. Nonetheless, the search for mechanisms of carcinogenesis-likely to be chemical specific-must continue.
In this vein, Ashby (1) urges me to identify the white ravens in the a2p-globulin story. As that earlier paper, from which Ashby generously quotes my writing, was a more broadened view of the visible white ravens in the overall hypothesis of chemically induced cell proliferation and cancer (6) , I did not identify the specific chemical exceptions to the a2p-globulin hypothesis. I had given the names of those chemicals in previous papers (7, 8) (13, 14) . Also, this chemical has been reported to induce a2p-globulin; yet, the predicted renal tubular cell tumors were not found in these studies (15) . Maintenance antiepileptic doses for this therapeutic agent range from 1,200 to 2,400 mg/day, but "the dose required to achieve control of seizures may be much higher" (16) . Thus, doses of gabapentin may be as high as 50-100 mg/kg in humans, not far removed from the lowest dose causing tumors in animals.
Lindane. The y-isomer of hexachlorocyclohexane, lindane, induces a2p-globulin nephropathy (17) without causing tumors of the kidney in long-term carcinogenicity studies (18) . Tumors of the liver in mice and of the thyroid gland in rats were induced following long-term exposure to lindane (18) (19) (20) .
Decalin. Decalin is probably the first chemical for which no empirical connection could be made between induced hyaline droplet-a2p-globulin nephropathy syndrome and cancer of the renal tubular epithelial cells (21) . In these experiments, male and female Fischer 344 rats and female C57BI/6 mice were exposed to decalin vapor at concentrations of 0, 5, or 50 ppm for 13 (23, 24) .
These authors concluded that
The spectrum of kidney lesions seen in the male rat given DMMP is similar to that seen after the long-term administration of a variety of other chemicals including unleaded gasoline, hydrocarbon solvents, and 1,4-dichlorobenzene.
The authors go on to suggest that the kidney le,sions were associated with hyaline droplet nephropathy and, although not measured, specifically to (x2p-globulin.
Two (25, 26) . TBA did induce kidney tumors, yet the coincidental occurrence of other lesions in both controls and exposed animals makes one pause in declaring this association as causal. Interestingly, as in DMMP, TBA induces hyperplasia of transitional epithelial cells in addition to the typical ex2p-globulin nephropathy. Also, TBA causes tumors of the thyroid gland in mice, another new finding for a2p-globulin chemicals. Suspicion about this posed mechanism is also raised by the observations of similar toxicity in both controls and exposed male rats: mineralization, severity of nephropathy, and renal tubular cell hyperplasia. The obvious questions are why the controls exhibit toxicities of the kidney very similar to the exposed animals although they were not exposed to TBA or why the exposed animals only had lesions similar in severity and incidence to the controls. This could mean no more than a typical late stage nephropathy seen in most male rats, and in these studies, female rats also exhibited end-stage nephropathy.
Using step-sectioning of the kidney, tubular cell tumors were found in 16% of controls versus 25%, 38%, and 26% of the three TBA-dosed groups (27) and causes cancer in several species [rat, liver and kidney (28) ; hamster, liver and thyroid gland (29) ; mouse, liver (29) ] and in a two-generation study in rats, parathyroid and adrenal glands (20, 30) . HCB is the first chemical identified that exhibits the a2p-globulin nephropathy sequelae, and induces renal cell tumors in both genders of rats.
Tubular cell tumors of the kidney were found more often and apparently earlier in male rats than in females (28) . In these HCB studies, even lower exposure regimens would have likewise been associated with renal tumor induction, especially in males. In females, one might view the dose response-tumor induction pattern as being perfectly correlated with chemical exposure (that is, double the exposure concentration and double the tumor response) although tumor rates were not age-adjusted for possible differences in survival (28) . Further, three types of the liver tumors were observed in HCB-exposed Sprague Dawley rats, with females being more responsive than males. Whether competing risk factors or the commonly later-occurring kidney tumors in females influenced these numerical differences of HCB-induced renal carcinogenesis remains to be ascertained.
Using two protocols (100 mg/kg/day for 15 days and 50 mg/ kg/day for 50 days), Bouthillier et al. (27) observed only in males degenerative and regenerative cellular foci, along with accumulation of protein droplets, in epithelial cells of the proximal tubules in both HCB experiments. Renal functional alterations were seen with the longer exposure. a2p-Globulin was increased 11-fold in male rats compared to controls (apparently not measured in females), and HCB was found to be bound reversibly to a2fp-globulin. Authors conclude "that HCB induces a male rat specific nephropathy that could explain the higher incidence of kidney tumors in male rats compared to female rats," and "protein droplets ... are considered to represent the initial step toward specific kidney tumor formation in male rats compared to female rats" (27) .
Because HCB induces tumors of the kidney in female as well as in male rats (by different mechanisms? and do these different mechanisms influence renal tumor induction and incidence in male rats, too?) and HCB induces various and unusual tumor types at high incidences in both sexes of three rodent species, other interpretations must be considered. Alternate theories have been proposed (3) (4) (5) Given the above exceptions to the rule, perhaps a new look needs to be given to the postulated association between a2p-globulin production and renal tumors in male rats and their relevance to public health. After all, 1) the accumulated data given above preclude any blanket endorsement of the a2p-globulin-mechanism, especially given that 2) so far, only one chemical, d-limonene, has been associated singularly with the a2p-globulin syndrome and kidney tumors in male rats, with no other tumors in female rats or in male or female mice; 3) in all cases that have been proposed to evoke the a2p-globulin theory, none of the chemicals exhibit any greater incidences of renal cell tumors than do non-Xa2p-globulin inducing chemicals, and most exhibit poor dose response curves; and 4) the majority of chemicals that preferentially cause tubular cell tumors of the kidney predominantly in male rats do not provoke a2p-globulin, thus, not explaining the significant gender differences in this and other chemically induced specific organ site tumors (and in humans as well). Regarding this last point, i am convinced that if bioassays were conducted for longer periods of time, e.g., 30 -36 months, gender discrepancies for tumors of the kidney would become moot.
In our rightful quests to identify and define mechanisms of chemical carcinogenesis, we must remain vigilant during our pursuit to overcome any tendency to endorse or accept a mechanism before incontrovertible proof exists. For instance, early in the a2p-globulin metaphor, some were proposing that chemicals shown to induce cx2p-globulin in short-term studies Volume 104, Number 12 December 1996 * Environmental Health Perspectives
